GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TPCO Holding Corp (OTCPK:GRMWF) » Definitions » Research & Development

TPCO Holding (TPCO Holding) Research & Development : $0.00 Mil (TTM As of Mar. 2023)


View and export this data going back to 2020. Start your Free Trial

What is TPCO Holding Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. TPCO Holding's Research & Development for the three months ended in Mar. 2023 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2023 was $0.00 Mil.

TPCO Holding Research & Development Historical Data

The historical data trend for TPCO Holding's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TPCO Holding Research & Development Chart

TPCO Holding Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Research & Development
- - - -

TPCO Holding Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

TPCO Holding Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TPCO Holding  (OTCPK:GRMWF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

TPCO Holding Research & Development Related Terms

Thank you for viewing the detailed overview of TPCO Holding's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

TPCO Holding (TPCO Holding) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TPCO Holding Corp (OTCPK:GRMWF) » Definitions » Research & Development
Comparable Companies
XCNQ:MMEN TSX:HEXO XCNQ:RVV XCNQ:BHSC XCNQ:INNO XCNQ:RIV XCNQ:GWAY TSX:XLY XCNQ:ACRG.A.U TSX:CRDL XTER:MRK ZTS TSE:4502 NSE:SUNPHARMA CTLT TSE:4507 SHSE:600196 SZSE:000538 VTRS NSE:DIVISLAB
Traded in Other Exchanges
N/A
Address
1550 Leigh Avenue, San Jose, CA, USA, 95125
Website
https://www.theparent.co
TPCO Holding Corp is a consumer-focused cannabis company based in the United States focused on the recreational and wellness markets. Its operational footprint spans cultivation, extraction, manufacturing, distribution, brands, retail and delivery. The company's sales channels include Direct Consumer and Wholesale, of which key revenue is derived from the Wholesale channel which includes the company selling first-party and selected third-party products into 450 dispensaries across California. Additional wholesale revenue comes from sales of sourced bulk flowers and oil produced in-house. It has one segment engaged in the cultivation, manufacturing, distribution and sale of cannabis within the State of California.